InspireMD’s CGuard Prime Embolic Prevention System (EPS) has secured CE Mark approval under the European Medical Device ...

There are more than 100,000 people on organ transplant lists in the U.S., some of whom will wait years to receive one—and ...

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC ...

The research was undertaken by world-renowned mRNA and cell therapy scientists and clinicians at the University of Pennsylvania. Chief scientific officer at Penn’s Perelman School of Medicine ...

The advance promises to improve diabetes research and cell-based ... Researchers Identify a Dual Origin of Cells Controlling Puberty and Reproduction May 21, 2025 — Researchers have shown that ...